Carbadox Competitive Antibody Pair

AccuSift
CBD
SKU Name Unit Price Delivery QTY
SR254 Carbadox monoclonal antibody 1mg $700 10days
TC254 Carbadox BSA antigen 1mg $266.6 10days
AccuSift provides high-performance Carbadox competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

Carbadox is a quinoxaline-type veterinary antimicrobial agent. It inhibits both Gram-negative bacteria (e.g., E. coliSalmonella) and Gram-positive bacteria (e.g., Staphylococcus). It was primarily used to control swine dysentery and bacterial enteritis, and was historically used as a feed additive to promote livestock growth.
Carbadox has been banned in many countries due to animal studies demonstrating carcinogenicity and teratogenicity. China's Ministry of Agriculture and Rural Affairs listed it in the "List of Drugs and Other Compounds Prohibited for Use in Food-Producing Animals" through Announcement No. 250 in 2020.
Performance Characteristics:

Sensitivity: ELISA IC50: 5 ppb

Cross-Reactivity: Cyadox 5 ppb

Source: Mouse Monoclonal Antibody

Purity: ≥ 90%

Recommended Pairing: (Coating) / (Labeling)

Storage: Long-term storage at ≤ -20°C; short-term storage at 2-8°C. Shipped on ice packs.


Operation

References